Results 11 to 20 of about 1,463,832 (396)

Nasopharyngeal Myoepithelial Carcinoma Mimicking Nasopharyngeal Carcinoma [PDF]

Journal of Cancer Research and Practice, 2015
AbstractMyoepithelial carcinoma (malignant myoepithelioma) (MC) is a rare tumor, defined as a malignant salivary neoplasm composed almost exclusively of tumor cells with myoepithelial differentiation. It can arise in unusual location sites, such as the nasopharynx, and may be difficult to approach.
Ping-Ying Chang, Hsin-Chien Chen, Yi-Jen Peng, Hung-Wen Kao, Ching-Liang Ho, Chieh-Sheng Lu, Chieh-Sheng Lu   +6 more
openaire   +5 more sources

The role of the bacterial microbiome in the treatment of cancer

BMC Cancer, 2021
The human microbiome is defined as the microorganisms that reside in or on the human body, such as bacteria, viruses, fungi, and protozoa, and their genomes.
Zi-Kun Yu, Rui-Ling Xie, Rui You, You-Ping Liu, Xu-Yin Chen, Ming-Yuan Chen, Pei-Yu Huang   +6 more
doaj   +1 more source

Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China

JAMA Oncology, 2022
Key Points Question Is there characteristic microbiota in nasopharyngeal carcinoma (NPC) tissues and, if so, is it associated with prognosis? Findings In this multicenter cohort study including 802 patients with NPC, we confirmed the existence of ...
Han Qiao, Xirong Tan, Hui Li, Junyan Li, Xiaozhong Chen, Yingqin Li, Wen-Fei Li, L. Tang, G. Zhou, Yuan Zhang, Yelin Liang, Qingmei He, Yin Zhao, Shengyan Huang, Sha Gong, Qian Li, Mingxia Ye, Kailin Chen, Ying Sun, Jun Ma, Na Liu   +20 more
semanticscholar   +1 more source

Accumulated Dose Deviation of Rotational and Residual Setup Errors on Nasopharyngeal Carcinoma Using MIM Treated by Helical Tomotherapy

Technology in Cancer Research & Treatment, 2023
Background To analyze the relationship between the rotational and residual setup errors and the dose deviation on nasopharyngeal carcinoma (NPC) treated by helical tomotherapy (HT).
Wenyan Yao MS, Jiang Hu MS, Peixun Xu BS, Mengxue He MS, Yongwen Fang BS, Mingzhi Liu BS, Zongtai Li BS, Huilang He MS, Hui Liu MS, Wenzhao Sun PhD, Senkui Xu MS   +10 more
doaj   +1 more source

Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma

International Journal of Molecular Sciences, 2022
c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) family members integrate signals that affect proliferation, differentiation, survival, and migration in a cell context- and cell type-specific way.
Lesley Jia Wei Pua, C. Mai, F. Chung, A. Khoo, C. Leong, W. Lim, Ling-Wei Hii   +6 more
semanticscholar   +1 more source

The Evolving Epidemiology of Nasopharyngeal Carcinoma

Cancer Epidemiology, Biomarkers and Prevention, 2021
Background: The epidemiology of nasopharyngeal carcinoma (NPC) has long been a source of fascination due to the malignancy's striking geographic distribution, the involvement of the oncogenic Epstein–Barr virus (EBV), the unique association with intake ...
E. Chang, W. Ye, Y. Zeng, H. Adami
semanticscholar   +1 more source

Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.

Journal of Clinical Oncology, 2021
PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy for patients with stage II-IVA nasopharyngeal carcinoma (NPC).
Yupei Chen, Nofisat Ismaila, M. Chua, A. Colevas, R. Haddad, Shao Hui Huang, Joseph Wee, Alexander C. Whitley, J. Yi, S. Yom, Anthony T. C. Chan, Chaosu Hu, J. Lang, Q. Le, Anne Lee, N. Lee, Jin-Ching Lin, B. Ma, Thomas J. Morgan, J. Shah, Ying Sun, Jun Ma   +21 more
semanticscholar   +1 more source

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. [PDF]

, 2014
PurposeWe hypothesized that bortezomib, an agent that suppresses HIF-1α transcriptional activity, when combined with bevacizumab, would obviate the HIF-1α resistance pathway.
Amin, Hesham M, Angelo, Laura S, Falchook, Gerald S, Hess, Kenneth, Hong, David, Howard, Adrienne N, Huang, Mei, Jackson, Edward F, Janku, Filip, Kurzrock, Razelle, Lawhorn, Kristie N, Naing, Aung, Ng, Chaan S, Parkhurst, Kristin L, Tannir, Nizar M, Vishwamitra, Deeksha, Wheler, Jennifer J   +16 more
core   +6 more sources

Unique case of inverted papilloma of septum with nasopharyngeal carcinoma:Is it a metachronous tumour? [PDF]

, 2020
Inverted papilloma is a rare and benign tumour. It affects the nasal cavity and paranasal sinuses, has a high rate of recurrence and is associated with malignant transformation.
Ferguson, Aaron S. J., Flach, Susanne, Manickavasagam, Jaiganesh, White, Paul S., White, Sharon   +4 more
core   +3 more sources

Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution

Nature Communications, 2021
The heterogeneous nature of tumour microenvironment (TME) underlying diverse treatment responses remains unclear in nasopharyngeal carcinoma (NPC). Here, we profile 176,447 cells from 10 NPC tumour-blood pairs, using single-cell transcriptome coupled ...
Yang Liu, Shuai He, Xiliang Wang, W. Peng, Qiu-Yan Chen, Dong-Mei Chi, Jie-Rong Chen, Bo W. Han, G. Lin, Yi-Qi Li, Qian-Yu Wang, Roujun Peng, Pan-Pan Wei, Xiang Guo, Bo Li, Xiaojun Xia, H. Mai, Xue-Da Hu, Zemin Zhang, Y. Zeng, J. Bei   +20 more
semanticscholar   +1 more source